Thalidomide: all 323 studies that test it
Page 3 of 4. Open to participants first (19), then studies with results posted, then the rest; newest registration first within each.
- Use of Thalidomide in Chronic UveitisTerminatedNCT00314665Phase 4
- SARCOTHAL. Thalidomide in Skin SarcoidosisCompletedNCT00305552Phase 3
- Open-Label Study of Thalidomide for Chronic Prostatitis/Chronic Pelvic PainTerminatedNCT00301405Phase 2
- Use of Thalidomide in Patients With ArachnoiditisCompletedNCT00284505Phase 2
- Combination Chemotherapy and Thalidomide in Treating Younger Patients Undergoing Surgery For Newly Diagnosed Liver CancerStatus unknownNCT00276705Phase 2
- Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative DisorderCompletedNCT00274820Phase 2
- Higher Frequency Zoledronic Acid in the Treatment of Multiple MyelomaCompletedNCT00263484Phase 2
- Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell LeukemiaCompletedNCT00258245Phase 1
- A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS TumorsCompletedNCT00251797Phase 1
- Trial of Thalidomide, a- Interferon +/- Octreotide in Patients With Unresectable Hepatocellular CarcinomaCompletedNCT00250796Phase 2
- PEG-Interferon Alfa-2b and Thalidomide in Treating Patients With Recurrent or Metastatic MelanomaCompletedNCT00238329Phase 2
- Melphalan, Prednisone and Thalidomide Versus Melphalan and Prednisone in Elderly Myeloma PatientsCompletedNCT00232934Phase 3
- Pilot-Study of Thalidomide in Amyotrophic Lateral Sclerosis (ALS)TerminatedNCT00231140Phase 2
- Arsenic Trioxide, Thalidomide, Dexamethasone, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple MyelomaTerminatedNCT00227682Phase 2
- A Trial of Thalidomide and Capecitabine in Metastatic Renal Cell CarcinomaCompletedNCT00226980Phase 2
- Phase III Trial of Oral Thalidomide in Advanced Hepatocellular Carcinoma With Poor Liver ReserveTerminatedNCT00225290Phase 3
- IFM 99-02 Thalidomide in MyelomaCompletedNCT00222053Phase 3
- Thalidomide to Patients With Previously Untreated Multiple MyelomaCompletedNCT00218855Phase 3
- Phase II Trial of Thalidomide in Refractory/Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin's DiseaseTerminatedNCT00209014Phase 2
- An Open Trial to Assess the Efficacy and Safety of Oral Thalidomide in Patients With Hormone-Refractory Prostate CancerCompletedNCT00201357Phase 2
- Arsenic Trioxide and Thalidomide in the Treatment of Refractory Multiple MyelomaCompletedNCT00193544Phase 2
- Thalidomide in Combination With Capecitabine in Patients With Metastatic Breast CancerTerminatedNCT00193102Phase 2
- Thalidomide, Dexamethasone, and Clarithromycin in Treating Patients With Multiple Myeloma Previously Treated With TransplantCompletedNCT00182663Phase 2
- Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem GliomaCompletedNCT00179881Phase 2
- A Trial of Thalidomide, Celecoxib, Etoposide and Cyclophosphamide in Patients With Relapsed or Progressive CancerCompletedNCT00165451Phase 2
- Thalidomide in Combination With Temodar in Patients With Neuroendocrine TumorsCompletedNCT00165230Phase 2
- Capecitabine and Thalidomide in Previously Treated Metastatic Colorectal CarcinomaCompletedNCT00165217Phase 2
- Treatment of Idiopathic Pulmonary Fibrosis With ThalidomideCompletedNCT00162760Phase 2
- Radiotherapy Plus Thalidomide in Locally Advanced Hepatocellular CarcinomaStatus unknownNCT00155272Phase 1/2
- Phase II Study Using Thalidomide for the Treatment of ALSCompletedNCT00140452Phase 2
- Thalidomide, Cyclophosphamide, Oral Idarubicin and Dexamethasone (T-CID) in Patients With Multiple MyelomaStatus unknownNCT00124813Phase 2
- Docetaxel and Thalidomide as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00114192Phase 2
- Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Multiple MyelomaWithdrawnNCT00112879Phase 2
- UARK 2005-01 Study of Velcade, Thalidomide, and Dexamethasone (VTD) With or Without Adriamycin® in Relapsed/Refractory PatientsCompletedNCT00111748Phase 3
- S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By SurgeryCompletedNCT00104988Phase 2
- Melphalan, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed, Previously Untreated Primary Systemic AmyloidosisCompletedNCT00089167Phase 2
- Dexamethasone or Dexamethasone in Combination With Thalidomide as Salvage TherapyCompletedNCT00083902Phase 2
- D.T. PACE Versus High Dose Melphalan and Autologous Transplant in Patients With Previously Treated Multiple MyelomaCompletedNCT00083876Phase 3
- Anti-Angiogenesis Therapy Using Thalidomide in Patients With Waldenstrom's MacroglobulinemiaCompletedNCT00083707Phase 2
- Thalidomide Anti-Angiogenesis Therapy of Relapsed or Refractory LeukemiaCompletedNCT00083694Phase 2
- DCEP in Combination With Thalidomide as Salvage Therapy for Post Transplantation RelapseCompletedNCT00083681Phase 2
- Anti-Angiogenesis Therapy Using Thalidomide in Multiple MyelomaCompletedNCT00083577Phase 2
- Study of Combination PS-341 and Thalidomide in Multiple MyelomaCompletedNCT00083460Phase 1
- Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and ThalidomideCompletedNCT00083408Phase 2
- Docetaxel, Estramustine, and Thalidomide in Treating Patients With Androgen-Independent Metastatic Adenocarcinoma of the ProstateCompletedNCT00083005Phase 2
- An Open Protocol for the Compassionate Use of ThalidomideCompletedNCT00081757Phase 1/2
- Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant GliomaCompletedNCT00079092Phase 2
- Temozolomide, Thalidomide, and Lomustine in Treating Patients With Unresectable Stage III or Stage IV MelanomaCompletedNCT00072345Phase 2
- Temozolomide and Thalidomide in Treating Patients With Brain Metastases Secondary to MelanomaCompletedNCT00072163Phase 2
- Irinotecan and Thalidomide in Treating Patients With Advanced Solid TumorsCompletedNCT00062127Phase 1
- Carboplatin and Etoposide With or Without Thalidomide in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung CancerCompletedNCT00061919Phase 3
- Epirubicin and Thalidomide in Treating Patients With Liver CancerCompletedNCT00058487Phase 2
- A Study of Combination Thalidomide Plus Dexamethasone Therapy vs. Dexamethasone Therapy Alone in Previously Untreated Subjects With Multiple MyelomaCompletedNCT00057564Phase 3
- Combination Chemotherapy and Thalidomide in Treating Patients With Stage I, Stage II, or Stage III Multiple MyelomaCompletedNCT00054158Phase 2
- Using the Drug Thalidomide to Stimulate T Cells in HIV-Infected PeopleCompletedNCT00053430Phase 2
- Thalidomide in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00053300Phase 2
- Fludarabine/Carboplatin/Topotecan w/Thalidomide for Relapsed/Refractory AML, CML and MDSCompletedNCT00053287Phase 2
- Thalidomide and Epoetin Alfa in Treating Anemia in Patients With Myelodysplastic SyndromeCompletedNCT00053001Phase 2
- Thalidomide in Treating Patients With Asymptomatic, Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaCompletedNCT00052416Phase 1
- A Study to Access the Safety/Efficacy of Thalidomide in the Treatment of Anemia in Patients With Myelodysplastic SyndromesCompletedNCT00050843Phase 3
- Oblimersen, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple MyelomaCompletedNCT00049374Phase 2
- Radiation Therapy Plus Thalidomide and Temozolomide in Treating Patients With Newly Diagnosed Brain MetastasesCompletedNCT00049361Phase 2
- Thalidomide and Docetaxel in Treating Patients With Advanced CancerCompletedNCT00049296Phase 1
- Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00047294Phase 2
- Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant GliomaCompletedNCT00047281Phase 2
- Docetaxel, Estramustine, and Thalidomide in Treating Patients With Prostate Cancer Previously Treated With Hormone TherapyCompletedNCT00046826Phase 2
- Thalidomide and Irinotecan in Treating Patients With Glioblastoma Multiforme Who Have Undergone Radiation TherapyCompletedNCT00039468Phase 2
- Study of Paclitaxel, Estramustine Phosphate and Thalidomide for Patients With Metastatic Androgen-Independent Prostate CarcinomaCompletedNCT00038246Phase 1/2
- Thalidomide for Multiple MyelomaCompletedNCT00038233Phase 3
- Preoperative Thalidomide Followed By Radical Retropubic Prostatectomy In Select Patients With Locally Advanced Prostate CancerCompletedNCT00038181Phase 2
- Thalidomide-Dexamethasone for Multiple MyelomaCompletedNCT00038090Phase 2/3
- Temozolomide and Thalidomide in Treating Patients With Metastatic, Locally Advanced, or Unresectable LeiomyosarcomaStatus unknownNCT00033709Phase 2
- Dexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple MyelomaCompletedNCT00033332Phase 3
- Radiation Therapy With or Without Thalidomide in Treating Patients With Brain MetastasesCompletedNCT00033254Phase 3
- Thalidomide in Treating Anemia in Patients With Myelodysplastic SyndromeCompletedNCT00030550Phase 2
- Combination Chemotherapy With or Without Thalidomide in Treating Patients With Multiple MyelomaStatus unknownNCT00028886Phase 3
- Interferon Alfa With or Without Thalidomide in Treating Patients With Metastatic Kidney CancerStatus unknownNCT00027664Phase 2
- Thalidomide in Treating Patients With Metastatic Neuroendocrine TumorsCompletedNCT00027638Phase 2
- Thalidomide in Treating Patients With Thyroid CancerCompletedNCT00026533Phase 2
- Interferon Alfa and Thalidomide in Treating Patients With Stage IV MelanomaCompletedNCT00026520Phase 2
- Interferon Alfa and Thalidomide in Treating Patients With Soft Tissue Sarcoma or Bone SarcomaStatus unknownNCT00026416Phase 2
- Thalidomide in Treating Patients With Recurrent or Persistent Endometrial CancerCompletedNCT00025467Phase 2
- Combination Chemotherapy Plus Thalidomide in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00025285Phase 2
- Thalidomide in Treating Patients With Recurrent or Persistent Cancer of the UterusCompletedNCT00025220Phase 2
- Bevacizumab With or Without Thalidomide in Treating Patients With Relapsed or Refractory Multiple MyelomaCompletedNCT00022607Phase 2
- Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaCompletedNCT00022581Phase 2
- Docetaxel With or Without Thalidomide in Treating Patients With Metastatic Prostate CancerCompletedNCT00020046Phase 2
- Thalidomide in Treating Patients With HIV-Associated Kaposi's SarcomaCompletedNCT00019123Phase 2
- Thalidomide and SU5416 in Treating Patients With Metastatic MelanomaCompletedNCT00017316Phase 2
- Thalidomide in Treating Patients With Refractory or Resistant Epithelial Ovarian CancerCompletedNCT00016224Phase 2
- Thalidomide in Treating Patients With Myelodysplastic SyndromeCompletedNCT00015990Phase 2
- Interferon Alfa Plus Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaTerminatedNCT00015912Phase 2
- Thalidomide in Treating Patients With MyelofibrosisCompletedNCT00015821Phase 2
- Topotecan and Thalidomide in Treating Patients With Recurrent or Refractory Malignant GliomaTerminatedNCT00014443Phase 2
- Thalidomide, Doxorubicin, and Dexamethasone in Treating Patients With Untreated Stage II or Stage III Multiple MyelomaCompletedNCT00008242Phase 2
- Thalidomide and Prednisone Following Peripheral Stem Cell Transplantation in Treating Patients With Multiple MyelomaCompletedNCT00006890Phase 2
- Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain TumorCompletedNCT00006358Phase 2
- Thalidomide in Treating Patients With Relapsed Chronic Lymphocytic LeukemiaCompletedNCT00006226Phase 2
- Thalidomide and Dacarbazine for Metastatic MelanomaStatus unknownNCT00006200Phase 2
- Chronic Thalidomide Administration in Patients Undergoing Chemoembolization for Unresectable Hepatocellular CancerStatus unknownNCT00006198Phase 2